| アブストラクト | During December 2018-February 2019, a multistate investigation identified 101 patients with vaccination-associated adverse events among an estimated 940 persons in Kentucky, Indiana, and Ohio who had received influenza; hepatitis A; pneumococcal; or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines at the workplace during September 11-November 28, 2018. These vaccines had been administered by staff members of a third-party health care company contracted by 24 businesses. Company A provided multiple vaccine types during workplace vaccination events across 54 locations in these adjoining states. Injection-site wound isolates from patients yielded Mycobacterium porcinum, a nontuberculous mycobacteria (NTM) species in the Mycobacterium fortuitum group; subtyping using pulsed-field gel electrophoresis of all 28 available isolates identified two closely related clusters. Site visits to company A and interviews with staff members identified inadequate hand hygiene, improper vaccine storage and handling, lack of appropriate medical record documentation, and lack of reporting to the Vaccine Adverse Event Reporting System (VAERS). Vaccination-associated adverse events can be prevented by training health care workers responsible for handling or administering vaccines in safe vaccine handling, administration, and storage practices, timely reporting of any suspected vaccination-associated adverse events to VAERS, and notifying public health authorities of any adverse event clusters. |
|---|
| 投稿者 | Blau, Erin F; Flinchum, Andrea; Gaub, Kathryn L; Hartnett, Kathleen P; Curran, Michael; Allen, Virginia K; Napier, Allison; Hesse, Elisabeth M; Hause, Anne M; Cathey, Rachel; Feaster, Christine; Mohr, Marika; de Fijter, Sietske; Mitchell, Sarah; Moulton-Meissner, Heather A; Benowitz, Isaac; Spicer, Kevin B; Thoroughman, Douglas A |
|---|
